These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38285640)

  • 1. Clonorchis sinensis infection amplifies hepatocellular carcinoma stemness, predicting unfavorable prognosis.
    Lin Q; Tang Z; Qin Y; Deng X; Wei C; Liu F; Pan X; Liu D; Zhan T; Fang M
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011906. PubMed ID: 38285640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonorchis sinensis infection contributes to hepatocellular carcinoma progression in rat.
    Qi Y; Hu J; Liang J; Hu X; Ma N; Xiang B
    Parasitol Res; 2022 Dec; 121(12):3403-3415. PubMed ID: 36266591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma.
    Shi Y; Jiang Z; Yang Y; Zheng P; Wei H; Lin Y; Lv G; Yang Q
    Parasitol Res; 2017 Oct; 116(10):2645-2649. PubMed ID: 28801696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Clonorchis sinensis combined with Hepatitis B virus infection on the prognosis of patients with Hepatocellular Carcinoma following Hepatectomy.
    Li YK; Zhao JF; Yang CL; Zhan GH; Zhang J; Qin SD; Zhou M; Li MJ; Huang JT; Kong FY; Huang H; Chen JH; Xiang BD
    PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011012. PubMed ID: 36638133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonorchis sinensis and clonorchiasis.
    Na BK; Pak JH; Hong SJ
    Acta Trop; 2020 Mar; 203():105309. PubMed ID: 31862466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy.
    Zhang J; Qin SD; Li Y; Lu F; Gong WF; Zhong JH; Ma L; Zhao JF; Zhan GH; Li PZ; Song B; De Xiang B
    World J Surg Oncol; 2022 Oct; 20(1):346. PubMed ID: 36258212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma.
    Xu M; Xie F; Qian G; Jing Y; Zhang S; Gao L; Zheng T; Wu M; Yang J; Wei L
    BMC Cancer; 2014 Feb; 14():65. PubMed ID: 24495509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Epithelial Cell Adhesion Molecule Cancer Stem Cell Marker in Evaluation of Hepatocellular Carcinoma.
    El-Kholy MA; Abu-Seadah SS; Hasan A; Elhussiny MEA; Abdelwahed MS; Hanbazazh M; Samman A; Alrashdi SA; Rashed ZF; Ashmawy D; Othman AE; Abdelaleem MF; Abo-Saif AIA; Abdel-Maqsoud RR; Attiah SM; Assiri ES; Nasr M; Ismail KA; Saad DZ; El-Mosely MM
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929532
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
    Lee SD; Park SJ; Han SS; Kim SH; Kim YK; Lee SA; Ko YH; Hong EK
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):594-601. PubMed ID: 25475861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
    World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of the "oval-cell" response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment.
    Lee JH; Rim HJ; Sell S
    J Hepatol; 1997 Jun; 26(6):1313-23. PubMed ID: 9210619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum CA19-9 indicates severe liver inflammation and worse survival after curative resection in hepatitis B-related hepatocellular carcinoma.
    Zhang W; Wang Y; Dong X; Yang B; Zhou H; Chen L; Zhang Z; Zhang Q; Cao G; Han Z; Li H; Cui Y; Wu Q; Zhang T; Song T; Li Q
    Biosci Trends; 2022 Jan; 15(6):397-405. PubMed ID: 34880159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
    An SL; Xiao T; Wang LM; Rong WQ; Wu F; Feng L; Liu FQ; Tian F; Wu JX
    Asian Pac J Cancer Prev; 2015; 16(10):4421-7. PubMed ID: 26028108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.